Invention Grant
- Patent Title: Treating conditions associated with increased eotaxin with 25-hydroxyvitamin D3
-
Application No.: US15393160Application Date: 2016-12-28
-
Publication No.: US10357501B2Publication Date: 2019-07-23
- Inventor: Stephanie Krammer-Lukas , Elisabeth Stoecklin , Joseph Schwager , Swen Wolfram
- Applicant: DSM IP ASSETS B.V.
- Applicant Address: NL Heerlen
- Assignee: DSM IP ASSETS B.V.
- Current Assignee: DSM IP ASSETS B.V.
- Current Assignee Address: NL Heerlen
- Agency: Nixon & Vanderhye P.C.
- Priority: EP10193847 20101206
- Main IPC: A61K31/59
- IPC: A61K31/59 ; A61K47/00 ; A61K31/593 ; A23L33/155 ; A61K9/00 ; A61K9/48
Abstract:
Methods for treating/preventing conditions associated with an increased level of eotaxin in a human with 25-hydroxyvitamin D3 (calcifediol) are provided. Optionally, vitamin D3 may be used together with 25-hydroxyvitamin D3.
Public/Granted literature
- US20170106005A1 TREATING CONDITIONS ASSOCIATED WITH INCREASED EOTAXIN WITH 25-HYDROXYVITAMIN D3 Public/Granted day:2017-04-20
Information query
